Avalo Therapeutics, Inc. (AVTX): SCHEDULE 13G/A filed Aug 7, 2026

Form type

SCHEDULE 13G/A

Filing date

Aug 7, 2026

Accession number

0000315066-26-002249

Filer

Avalo Therapeutics, Inc. (CIK 1534120)